K171446 is an FDA 510(k) clearance for the Cefaly Acute. This device is classified as a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II - Special Controls, product code PCC).
Submitted by Cefaly Technology (Seraing, BE). The FDA issued a Cleared decision on September 15, 2017, 122 days after receiving the submission on May 16, 2017.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5891. Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin..